Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Anticoagulant in percutaneous coronary intervention Age: Adult |
Dose: Intravenous – 0.75 mg/kg intravenous bolus dose followed immediately by a 1.75 mg/kg/h intravenous infusion Duration: Duration of the procedure Note: Five minutes after the bolus dose has been administered, an activated clotting time should be performed and an additional bolus of 0.3 mg/kg should be given if needed. Consider extending duration of infusion post-procedure up to 4 hours in patients with ST-segment elevation myocardial infarction. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Pediatric |
Dose: No approved pediatric dosage available Note: No approved pediatric dosage available |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment |
Dose: Bolus Dose – No reduction is required for any degree of renal impairment Note: No reduction is required for any degree of renal impairment |
|
Condition: Moderate renal impairment (Creatinine Clearance 30-59 mL/min) |
Dose: Intravenous infusion – 1.75 mg/kg/hour Frequency: continuous infusion |
Administration
- For IV use only
- Give as initial bolus followed by continuous infusion
Side Effect
- Back pain (42%)
- General pain (15%)
- Nausea (15%)
- Hemorrhage, minor (13.6%)
- Headache (12%)
- Hypotension (12%)
- Injection site pain (8%)
- Insomnia (7%)
- Pelvic pain (6%)
- Hypertension (6%)
- Anxiety (6%)
- Vomiting (6%)
- Bradycardia (5%)
- Dyspepsia (5%)
- Abdominal pain (5%)
- Fever (5%)
- Nervousness (5%)
- Urinary retention (4%)
- Hemorrhage, major (2.3%)
- More than 3g/dL fall in Hgb (1.9%)
- TIMI minor bleeding (1.3%)
- RBC transfusions (1.3%)
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Thrombolytics, oral Anticoagulants (Warfarin, Heparin, Dabigatran, Rivaroxaban, Apixaban, Edoxaban), drugs that affect platelet function
|
May increase risk of bleeding
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Active Bleeding, Severe Kidney Disease
|
Risk of bleeding complications
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store at temperature not exceeding 30º C in a dry place. Do not freeze. Keep out of reach of children
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.